Cdk Global Inc. (CDK): Sachem Head Capital Decreases Stake

Page 6 of 9 – SEC Filing
SCHEDULE 13D
CUSIP No. 12508E101
Page 6 of 9
This amendment No. 3 to Schedule 13D (this “Amendment No. 3”), amends and supplements the Schedule 13D (the “Original 13D”) filed on October 27, 2014 (the Original 13D, as amended and supplemented through the date of this Amendment No. 3, the “Schedule 13D”), by the Reporting Persons, relating to the common stock, par value $0.01 per share (the “Common Stock”), of CDK Global, Inc., a Delaware corporation (the “Issuer”).
This Amendment No. 3 is being filed to disclose a reduction in the beneficial ownership of the Reporting Persons of Common Stock as a result of sales of Common Stock.
Capitalized terms not defined in this Amendment No. 3 shall have the meaning ascribed to them in the Original 13D. Except as set forth herein, the Schedule 13D is unmodified.
ITEM 1.
SECURITY AND ISSUER
Item 1 of the Schedule 13D is hereby amended and supplemented to add the following information:
As of June 22, 2016, the Reporting Persons beneficially owned an aggregate of 8,750,162 shares of Common Stock, representing approximately 5.6% of the outstanding shares of Common Stock. The Reporting Persons also have additional economic exposure to approximately 3,152,667 notional shares of Common Stock under certain cash-settled total return swaps, bringing their total aggregate economic exposure to 11,902,829 shares of Common Stock, representing approximately 7.7% of the outstanding shares of Common Stock.

Follow Cdk Global Inc. (NASDAQ:CDK)